4 drug(s) with this reaction
4,167 total reports
Neutropenia has been reported as an adverse reaction across 4 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 4,167 adverse event reports mention neutropenia in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with neutropenia, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have neutropenia listed in their FDA adverse event reports, sorted by report count:
In addition to neutropenia, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
4 drug(s) manufactured by Abbvie Inc have neutropenia listed in their FDA adverse event reports: VENETOCLAX, DIVALPROEX SODIUM, RITONAVIR, LOPINAVIR AND RITONAVIR.
There are a combined 4,167 reports of neutropenia across 4 Abbvie Inc drug(s) in the FDA adverse event database.